Elutia terminates LeMaitre distribution deal, moves to direct cardiovascular sales

ELUTIA INC.

Termination of distribution agreement with LeMaitre Vascular for ProxiCor, VasCure, Tyke products in the U.S.
Appoints Dwayne Montgomery as Head of Cardiovascular; recruits 26 independent sales reps for new direct sales unit.
Expects ~80% gross margins and top-line growth; 2024 cardiovascular product sales were $2.9M (12% of revenue).
No early termination penalties incurred; transition to direct sales has commenced.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.